Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor

Surgical Oncology
Christos Markopoulos

Abstract

Neoadjuvant therapy improves patient outcomes substantially by increasing the rate of breast-conserving surgery. Following primary surgery, women with hormone-sensitive early breast cancer remain at risk for loco-regional and systemic recurrence. The most common relapse event, distant metastases, is associated with the poorest outcomes. As a neoadjuvant therapy, anastrozole, letrozole, and exemestane have been investigated in phase 3 studies and have shown efficacy in this setting. All three aromatase inhibitors (AIs) significantly improved the rate of breast-conserving surgery. As initial adjuvant therapy, the third-generation AIs anastrozole and letrozole more effectively reduce recurrence risk compared with tamoxifen following surgery, especially in the first 2 years, when the risk is greatest. Tamoxifen, once the standard initial therapy, is associated with improved disease-free survival but may be more effective at reducing loco-regional recurrence than distant metastases. Initial adjuvant letrozole therapy has also shown a pronounced reduction in the risk of distant metastases early on in the course of therapy. If AIs are not used upfront, sequential use of exemestane or anastrozole following tamoxifen provides greater pr...Continue Reading

References

Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·F LeborgneE Zubizarreta
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L LoprinziTeresa A Rummans
Nov 21, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M DixonW R Miller
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerUNKNOWN American Society of Clinical Oncology
Dec 23, 2003·Journal of General Internal Medicine·R Scott BraithwaiteNananda F Col
May 6, 2004·Journal of the National Cancer Institute·Rabiya S Tuma
Aug 4, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole Hébert-CroteauGinette Martin
Sep 21, 2004·Breast Cancer Research and Treatment·Sindy OhPatricia A Ganz
Jan 6, 2005·Journal of the National Cancer Institute·Yan JinDavid A Flockhart
May 13, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B C PestalozziUNKNOWN ESMO Guidelines Task Force
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy J Whelan, Kathleen I Pritchard
Aug 5, 2006·The Lancet Oncology·UNKNOWN Arimidex, Tamoxifen, Alone or in Combination Trialists' GroupJ M Nabholtz
Sep 19, 2006·American Journal of Surgery·Jennifer R GarreauNathalie Johnson
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy Jo Chien, Paul E Goss
Dec 6, 2006·Seminars in Oncology·Cynthia X Ma, Matthew J Ellis
Jan 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan S CoatesAron Goldhirsch
Jan 16, 2007·Breast Cancer Research and Treatment·Carol J FabianBrian K Petroff
Feb 16, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L MauriacUNKNOWN International Breast Cancer Study Group
Mar 21, 2007·The Breast : Official Journal of the European Society of Mastology·Harold J Burstein
Mar 27, 2007·Nature Reviews. Cancer·M Carolina HinestrosaFrances M Visco
Apr 10, 2007·The Breast : Official Journal of the European Society of Mastology·Sadako Akashi-TanakaTakashi Fukutomi
Apr 24, 2007·The Breast : Official Journal of the European Society of Mastology·Yvonne WengströmVasoulla Georgiou
May 15, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Valerie JenkinsLesley Fallowfield
Jun 8, 2007·The New England Journal of Medicine·Rinaa S PungliaJay R Harris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.